On the evening of February 27th, biotechnology company Bloomage Biotechnology Corp., Ltd. (Bloomage) (SH:688363) released its 2022 annual performance report, stating that the company achieved a revenue of 6.359 billion yuan, an increase of 28.53% compared to the same period last year. The net profit attributable to shareholders was 970 million yuan, an increase of 24.00% compared to the same period last year. After deducting non-recurring gains and losses, the net profit attributable to shareholders was 863 million yuan, an increase of 30.06% year-on-year.
As of the close of February …
